Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
In recent weeks, MAIA Biotechnology (NYSE: MAIA) has garnered significant attention from investors and analysts alike. The company, focused on developing innovative...